MedTrace Logo

The Orkdal Model. Collaboration Between Specialist and Community Care Within Palliative Cancer Care

NCT02170168 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 969

Last updated 2023-04-13

No results posted yet for this study

Summary

The overall aim of this project is to deliver better health care services through improved coordination of cancer care within specialist care (at the local hospital Orkdal Hospital) and community care (13 municipalities in the Orkdal region, Norway), and between these two levels in the health care system. "The Orkdal model" is developed and will be implemented and evaluated within cancer care. Cancer patients living in one of the 12 municipalities participating in the formal collaboration "Samhandlingsenheten i Orkdalsregionen" (SIO), or the municipality of Oppdal, having metastatic and/or loco-regional disease will be included in the study. Carers and health care providers will be included as well. Results from this project will be transferable to other parts of Norway and/or to other countries as well as to patients with other diagnoses causing complex conditions, such as chronic heart-, lung- and neurological disease.

Conditions

  • Neoplasms

Interventions

OTHER

integrated palliative care program

a standardised care pathway, an educational programme and information to general public, patients and their carers

Sponsors & Collaborators

  • The Coordination Unit in the Orkdal region (SIO)

    collaborator UNKNOWN

  • Helse Møre og Romsdal HF

    collaborator OTHER_GOV

  • Norwegian University of Science and Technology

    collaborator OTHER

  • St. Olavs Hospital

    lead OTHER

Principal Investigators

  • Jo-Åsmund Lund, MD PhD · St. Olavs Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2022-03-31
Completion
2022-09-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02170168 on ClinicalTrials.gov